Sagimet Biosciences Inc. (SGMT) has a consensus analyst rating of Buy, based on 6 analysts covering the stock. Of those, 5 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for SGMT is $8.00, representing a +44.4% upside from the current price of $5.54. Price targets range from a low of $8.00 to a high of $8.00.
